CN101129825A - Traditional Chinese medicine for preventing relapse of coronary disease - Google Patents

Traditional Chinese medicine for preventing relapse of coronary disease Download PDF

Info

Publication number
CN101129825A
CN101129825A CNA2007100260136A CN200710026013A CN101129825A CN 101129825 A CN101129825 A CN 101129825A CN A2007100260136 A CNA2007100260136 A CN A2007100260136A CN 200710026013 A CN200710026013 A CN 200710026013A CN 101129825 A CN101129825 A CN 101129825A
Authority
CN
China
Prior art keywords
blood
disease
coronary
chinese medicine
coronary disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2007100260136A
Other languages
Chinese (zh)
Other versions
CN100563701C (en
Inventor
张伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2007100260136A priority Critical patent/CN100563701C/en
Publication of CN101129825A publication Critical patent/CN101129825A/en
Application granted granted Critical
Publication of CN100563701C publication Critical patent/CN100563701C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a Chinese medicinal preparation for treating coronary heart disease, which is prepared from raw materials of ginseng, dry human placenta, ganoderma lucidum, Chinese caterpillar fungus, amber, root of red rooted saliva, Ligusticum wallichii, safflower, hairy deerhorn, dragon's blood resin, notoginseng, buthus martensi karsch, leeches, centipede, batryticated silkworm, earthworm and Eupolyphaga Sinensis Walker.

Description

The Chinese medicine of prevention relapse of coronary disease
Technical field
The present invention relates to a kind of Chinese medicine, specifically is a kind of Chinese medicine that prevents relapse of coronary disease.
Background technology
Coronary heart disease is one of important diseases of harm humans health, be human life's first killer, though Western medicine and interventional therapy have been saved thousands of coronary disease patients' life, but a new difficult problem and puzzlement have been produced after the treatment, as: there is not flow phenomenon again, the formation again of thrombosis speckle, sequela such as the damage during operation, the effect time limit of interventional therapy makes the life of patients with coronary heart disease still be subjected to serious threat, and this just makes the last ens morbi of controlling of the traditional Chinese medical science " prevention of diseae be disease preapre for an unfavorable turn of events rehabilitation after being ill " demonstrate remarkable advantages in coronary cardiopathy rehabilitation even radical cure.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine that prevents relapse of coronary disease, can effectively prevent the recurrence again after coronary heart disease is alleviated.
The objective of the invention is to realize with following technical scheme: a kind of Chinese medicine that prevents relapse of coronary disease, make by following raw medicaments in portion by weight:
Radix Ginseng 40-80 part Placenta Hominis 40-80 part Ganoderma 40-80 part
Cordyceps 10-40 part succinum 40-80 part Radix Salviae Miltiorrhizae 40-part
Rhizoma Chuanxiong 40-80 part Stigma Croci 10-40 part Cornu Cervi Pantotrichum 10-40 part
Sanguis Draxonis 10-40 part Buxus sinica (Rehd.et Wils.) 10-40 part Radix Notoginseng 40-80 part
Scorpio 10-40 part Hirudo 10-40 part Scolopendra 10-40 part
Bombyx Batryticatus 10-40 part Pheretima 10-40 part Eupolyphaga Seu Steleophaga 10-40 part.
The system preparation method: will be above-mentioned the strict screening of 18 flavor medicines, select for use and do not have the authentic medicinal herbs that rots to go mouldy, drying or dry the back with pulverizer pulverizing (100 orders-150 order) is mixed even.Adorn capsule behind the autoclave sterilization No. 0, every pill 0.3g, sealing is preserved.
Usage: each oral 6 of coronary disease patient, warm water delivery service, every day 3 times, 120 days is a course of treatment.
Points for attention: 1. enalapril meleate, angina pectoris medicine patient continue to take, when clothes medicine first quarter moon of the present invention is withdrawn depressor, angina pectoris medicine more gradually to January.2. the serious Liver and kidney capsule person of exhausting prohibits clothes.Prohibit clothes when 3. the ACA myocardial infarction is shown effect.4. there is allergy sufferers to prohibit clothes to Chinese medicine.
The present invention also can extract the above-mentioned raw materials the effective elements of the medicine, and preparation method of Chinese medicine is made capsule or dosage forms such as electuary or unguentum routinely.
The side separates: element culturing fixed folder activating blood circulation to dissipate blood stasis dredge the meridian passage regulating QI to relieve pain.Element culturing fixed folder is exactly to replenish vigour, vigour is the necessary vital essence of human life activity, be the power that breaks the functional activity of moving body internal organs, it promptly is the designate of cereal nutrient, it also is the performance of functional activity, vigour has at human body breaks old merit of hitting new warm internal organs defence exopathogen, and the people has life, the complete time gas that relies, vigour is full, the people can be at the age of one hundred years old, and insufficiency of primordial QI moves not normal, all kinds of diseases and ailments are all living, can cause that disease is turbid, diseases caused by retention of fluid, congestion, cause function disorderly plain, coronary heart disease is exactly out of control and cause a series of clinical manifestations such as shortness of breath and palpitation chest pain in vigour.Ancients' cloud: " qi as the commander of blood, blood being the mother of qi, and the capable then blood of gas is capable, and the deficiency of vital energy is blood stasis then, the then blood resistance of silt is exhausted until life ", the sufficient cardiac pumping of vigour is strong, and life is vigorous.In the emperor through the argumentation of cloud " qi as the commander of blood, it is capable that gas breaks blood, so stagnation of QI blood is not all right, and the stasis of blood that arrives ", the human disease of the giving birth to result that to be exactly vigour win mutually with pathogen.Rehabilitation and the crucial element culturing fixed folder tonifying vital QI of radical cure coronary heart disease, the vigour foot is evil irrelevant, and disease is not fought and is healed.
Therefore select Radix Ginseng, Placenta Hominis, Ganoderma, Cordyceps, Cornu Cervi Pantotrichum, succinum, element culturing fixed folder tonifying vital QI enhancing immunity for use, stride forward to radical cure until rehabilitation.
Medicine is separated:
Radix Ginseng: strongly invigorating primordial QI, reinforcing the heart gas again, promoting blood circulation is only pained, and multiple arteries and veins takes off admittedly, spleen reinforcing benefit brain, the merit of promoting the production of body fluid and inducing sedation of the mind.
Ganoderma: tonify deficiency is set upright, mind tranquilizing and the heart calming, defying age antioxidation, strengthening by means of tonics function.
Cordyceps: mend vital essence, high aspiration gas, decreasing heart rate increases heart throughput rate and coronary flow, tangible arrhythmia is arranged, functions such as blood pressure lowering.
Placenta Hominis: mend congenitally greatly, augment QI and blood, strengthen human immunity, impel tissue regeneration to grow.
Cornu Cervi Pantotrichum: warming and recuperating the kidney-YANG, the benefiting essence-blood bone and muscle strengthening can make heart rate accelerate, and increases stroke volume, the angioplerosis increased blood pressure, hear sounds is strong, and the hat blood flow increases.
Succinum: centering is sent out refreshing, and arrhythmia and Panax pseudoginseng are share, and QI and blood is become silted up hinder, and breast low costalgia has special effect.
Activating blood circulation to dissipate blood stasis opinion: consolidate and do not forget to uncharm, evilly win that this is more empty, the resistance of blood stasis benefit, QI and blood is obstructed is coronary heart disease to the beginning to one of whole main performance, blood circulation promoting and blood stasis dispelling is that treatment coronary heart disease is removed one of main way of clinical symptoms.The stasis of blood does not go arteries and veins obstructed, breast more the pain gas more empty, so select for use: Radix Salviae Miltiorrhizae, river virtue, Stigma Croci, Sanguis Draxonis, Radix Notoginseng, Buxus sinica (Rehd.et Wils.), invigorate blood circulation, blood stasis dispelling, regulate the flow of vital energy, pain relieving.
Medicine is separated: Radix Salviae Miltiorrhizae: the blood stasis removing pain relieving, and promoting blood circulation to restore menstrual flow, the relieving restlessness that clears away heart-fire has coronary dilating shape blood vessel, and blood fat-reducing blood pressure-decreasing resists myocardial ischemia, anticoagulation, antiplatelet aggregation and thrombosis strengthen anoxia enduring power.
Rhizoma Chuanxiong: blood-activating and qi-promoting, stasis-dispelling and pain-killing, the coronary artery dilator coronary blood flow increasing reduces whole blood viscosity, and anti-blood plate is assembled.
Stigma Croci: promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain, the merit of removing pathogenic heat from blood and toxic substance from the body has excited heart, increases the coronary flow blood fat-reducing blood pressure-decreasing, suppresses thrombosis and assembles the effect of microcirculation improvement.
Sanguis Draxonis: blood-activating analgetic, significantly anticoagulant prevents thrombosis, the ARR effect of anti-myocardial ischemia.
Radix Notoginseng: strengthening by means of tonics, hemostasia and dissipation blood stasis, subduing swelling and relieving pain has hemostasis and does not stay the stasis of blood, blood stasis dispelling and the merit of not blood coagulation, have coronary artery dilator, coronary blood flow increasing resists myocardial ischemia, antioxidation, defying age, hypertension and hyperlipemia, anticoagulant promotes the effect of fibrinolytic.
Buxus sinica (Rehd.et Wils.): (can select Buxus sinica (Rehd.et Wils.) abstract " Buxus sinica (Rehd.et Wils.) " for use) has promoting flow of QI and blood, removing obstruction in the collateral to relieve pain, and blood vessel dilating, coronary blood flow increasing reduces myocardial oxygen consumption, positive inotropic action.
The dredge the meridian passage opinion: the coronary heart disease course of disease is long, and medical history is touching, and very easily Fu Fa network disease is just sick, draft class pharmacology gas invigorate blood circulation still can, then stasis of blood expectorant glue is chronic for a long time, the heavy prescription of non-removing blood stasis is difficult to gather effect, worm ant class medicine, the depletion of blood person is flat, and the person walks blood blood, no person's liter, the person of walking falls, and is agile rapid, make blood not have the work of coagulating, gas can be unimpeded, but root pine expelling pathogenic factors from the exterior chases after and pulls out heavy heresy of mixing QI and blood." plain what regulating menstruation opinion " points out that " sick network at blood accents " " Linzheng Zhinan Yi " emphasize that also " through main gas; network is lived blood " " just being depressed at warp; then blood is hindered into network for a long time " " medical center changes golden person " emphasize that " prolonged illness people network is the stasis of blood " illustrates that the network disease is the disease of blood stasis, so select for use insect medicine Hirudo, Scorpio, Scolopendra, Eupolyphaga Seu Steleophaga, Bombyx Batryticatus, groundbed to go deep into the tunnel network, attack the stasis of blood expectorant that picks chronic knot, turn dynamic resistance vigour can be brought into play beyond thought effect.
Medicine is separated: 1. Hirudo: hirudin is the specially good effect element of antithrombase, has the thrombolytic effect of thromboembolism preventing anticoagulant, can reduce the effect that whole blood viscosity and fiber protein content increase the myocardial nutritional flow amount.
2. groundbed: clearing heat for calming endogenous wind, the diuresis collateral dredging has the blood pressure lowering calmness, antithrombotic, fibrinolysis.
3. Scorpio: the endogenous wind stopping collateral dredging, bright convulsion pain relieving has the anti-senility anti-fatigue effect.
4. Bombyx Batryticatus: the eliminating stagnation of expellingging wind and relieving convulsion has obvious effect for reducing fat.
5. Eupolyphaga Seu Steleophaga: removing blood stasis, the blood and relieving pain that looses, it has thrombolytic, suppresses platelet aggregation and release, and cholesterol reducing improves the heart ischemia anoxia endurance, reduces oxygen consumption.
6. Scolopendra: expelling wind and relieving convulsion, removing obstruction in the collateral to relieve pain, bright malicious eliminating stagnation has blood pressure lowering and resists myocardial ischemia, anti-oxidation function.
More than 18 flavor medicine integrated applications evident in efficacy to coronary heart disease myocardial infarction convalescent period, relapse rate is low, is subjected to the favorable comment of vast patients with coronary heart disease deeply.
The invention has the beneficial effects as follows: the present invention is that the inventor is according to facing the Chinese medicine of the prevention relapse of coronary disease of bed experience development for many years, take motherland's medical science one-to-many, many target spots element culturing fixed folder treatment coronary heart disease is the basic treatment at disease, reduces recurrence even radical cure to a great extent.Evident in efficacy.
The specific embodiment
Further specify the present invention and effect below in conjunction with embodiment and efficacy analysis.
Embodiment 1
Crude drug:
Radix Ginseng 60 gram Placenta Hominiss 60 kairine sesames 60 grams
Cordyceps 30 gram succinums 60 gram Radix Salviae Miltiorrhizaes 60 grams
Rhizoma Chuanxiong 60 gram Stigma Crocis 30 gram Cornu Cervi Pantotrichums 30 grams
Sanguis Draxonis 30 gram Buxus sinica (Rehd.et Wils.) 30 gram Radix Notoginseng 60 grams
Scorpio 30 gram Hirudos 30 gram Scolopendras 30 grams
Bombyx Batryticatus 30 gram Pheretimas 30 gram Eupolyphaga Seu Steleophagas 30 grams.
Preparation method: with the strict screening of above-mentioned 18 flavor medicines, select for use and do not have the authentic medicinal herbs that rots to go mouldy, drying or dry the back and pulverized 100 orders-150 mesh sieve with pulverizer is mixed even.Adorn capsule behind the autoclave sterilization No. 0, every pill 0.3g.
Experimental example: clinical observation on the therapeutic effect.
(1) ordinary circumstance.
Since two thousand one treat people surplus the patients with coronary heart disease 200 altogether, 66 people that the regular follow-up record is arranged, male 47 people, women 19 people, age 47-82 year, course of disease 1-36, coronary heart disease is angor 36 people whole-heartedly, weak asthma 54 people of cardiopalmus, myocardial infarction medical history person 17 people are arranged, companion's arrhythmia 28 people have hypertension history 42 people, companion's hyperlipemia 39 people.
(2) use medicine: embodiment 1 gained capsule.
(3) Therapeutic Method: each oral 6 of coronary disease patient, warm water delivery service, every day 3 times, 120 days is a course of treatment.
(4) efficacy evaluation:
1. produce effects: 42 people account for 64%.One course of treatment of medication, stop using behind all medicines, follow up a case by regular visits to 2-3 and do not have recurrence.
2. effective: 16 people account for 24%.One course of treatment of medication, all medicines of stopping using are followed up a case by regular visits to 1-2, do not have recurrence, or sense of discomfort before slightly having the inclination.Just recovered normal in oral once more medicine 1-5 of the present invention days, patient is that the long older complication of the course of disease is controlled the patient of not imitating more.
3. take a turn for the better: 6 people account for 9.0%.One course of treatment of medication, condition of illness takes a turn for the better, but not lasting or only a certain other symptom of sx of effect does not have obvious curative effects.
4. invalid: 2 people, 3.0% (atrial fibrillation heart table patient deficiency person's course of treatment)
Total effective rate reaches 97%.
Toxicity is observed: all patients all do not have toxic reaction, and about 5 patient has heartburn sense, very fast recovery or change into taking medicine after meal and get final product behind the oral ranitidine motilium.

Claims (1)

1. a Chinese medicine that prevents relapse of coronary disease is characterized in that, is made by following raw medicaments in portion by weight:
Radix Ginseng 40-80 part Placenta Hominis 40-80 part Ganoderma 40-80 part
Cordyceps 10-40 part succinum 40-80 part Radix Salviae Miltiorrhizae 40-part
Rhizoma Chuanxiong 40-80 part Stigma Croci 10-40 part Cornu Cervi Pantotrichum 10-40 part
Sanguis Draxonis 10-40 part Buxus sinica (Rehd.et Wils.) 10-40 part Radix Notoginseng 40-80 part
Scorpio 10-40 part Hirudo 10-40 part Scolopendra 10-40 part
Bombyx Batryticatus 10-40 part Pheretima 10-40 part Eupolyphaga Seu Steleophaga 10-40 part.
CNB2007100260136A 2007-08-14 2007-08-14 The Chinese medicine of prevention relapse of coronary disease Expired - Fee Related CN100563701C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2007100260136A CN100563701C (en) 2007-08-14 2007-08-14 The Chinese medicine of prevention relapse of coronary disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2007100260136A CN100563701C (en) 2007-08-14 2007-08-14 The Chinese medicine of prevention relapse of coronary disease

Publications (2)

Publication Number Publication Date
CN101129825A true CN101129825A (en) 2008-02-27
CN100563701C CN100563701C (en) 2009-12-02

Family

ID=39127337

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2007100260136A Expired - Fee Related CN100563701C (en) 2007-08-14 2007-08-14 The Chinese medicine of prevention relapse of coronary disease

Country Status (1)

Country Link
CN (1) CN100563701C (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102078336A (en) * 2011-01-11 2011-06-01 南京中医药大学 Traditional Chinese medicine composition with function of improving microcirculation and preparation method and application thereof
CN103285056A (en) * 2013-05-24 2013-09-11 张家界金鲵生物工程股份有限公司 Traditional Chinese medicine preparation for preventing and curing cardiovascular diseases and preparation method thereof
CN108392557A (en) * 2018-05-25 2018-08-14 王代金 A kind of drug and preparation method thereof for treating coronary heart disease
CN110038080A (en) * 2019-05-15 2019-07-23 刘智民 One kind is for treating cardiopathic Chinese patent drug and preparation method thereof
CN112107645A (en) * 2019-06-03 2020-12-22 北京南山缘医药科技有限公司 A Chinese medicinal composition for improving reproductive function and improving life quality
CN112843179A (en) * 2019-11-28 2021-05-28 祁东县柯佳特色医术研究所 Tongmai Guben powder and its preparation method and use

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102078336A (en) * 2011-01-11 2011-06-01 南京中医药大学 Traditional Chinese medicine composition with function of improving microcirculation and preparation method and application thereof
CN103285056A (en) * 2013-05-24 2013-09-11 张家界金鲵生物工程股份有限公司 Traditional Chinese medicine preparation for preventing and curing cardiovascular diseases and preparation method thereof
CN108392557A (en) * 2018-05-25 2018-08-14 王代金 A kind of drug and preparation method thereof for treating coronary heart disease
CN110038080A (en) * 2019-05-15 2019-07-23 刘智民 One kind is for treating cardiopathic Chinese patent drug and preparation method thereof
CN112107645A (en) * 2019-06-03 2020-12-22 北京南山缘医药科技有限公司 A Chinese medicinal composition for improving reproductive function and improving life quality
CN112843179A (en) * 2019-11-28 2021-05-28 祁东县柯佳特色医术研究所 Tongmai Guben powder and its preparation method and use

Also Published As

Publication number Publication date
CN100563701C (en) 2009-12-02

Similar Documents

Publication Publication Date Title
CN100341545C (en) Oral medicine for treating thromboangitis obliterans
CN1302805C (en) Ready prepared Chinese medicine for preventing and treating brain apoplexia
CN101637585B (en) Chinese herbal preparation for treating posirasis and preparation method thereof
CN103142953A (en) Foot-bath health-protective Chinese medicament powder
CN100563701C (en) The Chinese medicine of prevention relapse of coronary disease
CN101690764A (en) Traditional Chinese medicine for treating cardiac, cerebral and vascular diseases and preparation method thereof
CN102940865B (en) Externally applied medicament for treating rheumatoid arthritis and hyperosteogeny and preparation method thereof
CN1240416C (en) Medicine for curing hypertension and its preparation method
CN102861287B (en) Chinese medicinal composition for treating damp-heat invasion blood stasis diabetic foot and preparation method thereof
CN103041336A (en) Traditional Chinese medicine composition for treating coronary heart disease
CN101513470B (en) Chinese patent medicine for treating cervical vertebra disease
CN1181868C (en) Chinese medicine prepn for treating obliterans thromboangitis
CN102908425B (en) Medicine for treating heart diseases and thick blood lipid and preparation method of the medicine
CN1788766A (en) Oral Chinese traditional medicine for treating diabetes foot
CN1290545C (en) Medicine for curing coronary heart disease
CN103041119A (en) Traditional Chinese medicine for treating cardiac disease
CN102172375A (en) Traditional Chinese medicine for treating chronic hepatitis
CN104825635A (en) Traditional Chinese medicine composition for treating diabetic feet
CN104800772A (en) Traditional Chinese medicine composition for treating vital-energy-depression type coronary heart disease and application of traditional Chinese medicine composition
CN105434649A (en) Traditional Chinese medicine composition treating blood-stasis collateral-obstruction type diabetic foot
CN104491324A (en) Aerosol for postoperative patient to promote blood circulation and remove obstruction in channels
CN103055159B (en) Medicine for treating hypertension
CN108096536A (en) A kind of Chinese medicine composition for treating hemiplegia
CN102441096B (en) Disperse blood stasis and dredge collateral compound recipe pill and preparation method thereof
CN102526685A (en) Medicament for treating cervical spondylosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20091202

Termination date: 20100814